✦ LIBER ✦

Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy

✍ Scribed by M Deutsch; S Dourakis; E K Manesis; A Gioustozi; G Hess; A Horsch; S Hadziyannis

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 223 KB
Volume: 26
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510260127

No coin nor oath required. For personal study only.

✦ Synopsis

Group 1. Two hundred eleven patients with chronic hepatitis C

📜 SIMILAR VOLUMES

Thyroid abnormalities in patients with c

Thyroid abnormalities in patients with chronic viral hepatitis

✍ Miau-Ju Huang 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views

Predictors of a sustained beneficial res

Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C

✍ Hari S. Conjeevaram; James E. Everhart; Jay H. Hoofnagle 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 2 views

## Predictors of a Sustained Beneficial Response to Interferon Alfa Therapy in Chronic Hepatitis C Interferon alfa was first reported to have beneficial effects in chronic hepatitis C in the mid-l980s,' effects that were subsequently verified in multiple randomized controlled trials performed in

Antipyrine clearance and response to int

Antipyrine clearance and response to interferon therapy in chronic hepatitis

✍ A Fabbri; G P Bianchi; G Marchesini 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

In a recent publication by Panzar et al., 1 the authors have 55. used 400-to 1,000-d polyethylene glycol to study small intes-4. Lake JR, Licko V, van Dyke RN, Scharschmidt BF. Biliary secretion of fluid-markers by the isolated perfused rat liver. J Clin Invest 1985;76:676-tinal absorption in portac

Intrahepatic hepatitis C virus–specific

Intrahepatic hepatitis C virus–specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C

✍ David R. Nelson; Constantine G. Marousis; Tomoyoshi Ohno; Gary L. Davis; Johnson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes (CTL) have been shown to play a role in host defense and pathogenesis of chronic HCV infection. Our aim was to test the hypothesis that intrahepatic HCV-specific CTL activity may impact subsequent response to interferon alfa (IFN-␣) therapy. O

r-interferon alfa–2b/ribavirin combined

r-interferon alfa–2b/ribavirin combined therapy followed by low-dose r-Interferon alfa-2b in chronic hepatitis C interferon nonresponders

✍ A. Perasso; G. Testino; F. Ansaldi; V. Venturino; G.C. Icardi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 1 views

Prediction of response during interferon

Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison

✍ M J Tong; L M Blatt; J G McHutchison; R L Co; A Conrad 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

Patients with chronic hepatitis C (n Å 103) were treated cases of acute hepatitis C occur on an annual basis, and an estimated 8,000 to 10,000 deaths occur each year of compli-for 24 weeks with interferon alfa 2b and followed up for 24 weeks after cessation of therapy (week 48). When hepatitis catio